← Browse by Condition
Medical Condition
endometrial neoplasms
Total Trials
5
Recruiting Now
5
Trial Phases
Phase 1, Phase 2
NCT07114601 Phase 1
Recruiting
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Enrollment
421 pts
Location
United States, Canad...
Sponsor
Eli Lilly and Company
NCT06532539 Phase 2
Recruiting
Cadonilimab With Chemoradiation for Recurrent and Oligometastatic Endometrial Carcinoma
Enrollment
30 pts
Location
China
Sponsor
Shandong Cancer Hospital and I...
NCT05945407
Recruiting
Fertility-sparing Therapy for Patients With Stage IA Endometrial Cancer
Enrollment
57 pts
Location
China
Sponsor
Peking University People's Hos...
NCT05793749
Recruiting
Early Intervention to Prevent Lower Limb Lymphedema of Gynecological Malignancy
Enrollment
400 pts
Location
China
Sponsor
Chongqing University Cancer Ho...
NCT06023862 Phase 2
Recruiting
A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurrent Gynecological Clear Cell Carcinoma: DOVE (APGOT-OV7/ ENGOT-ov80 Study)
Enrollment
198 pts
Location
Japan, Singapore, So...
Sponsor
Yonsei University